Li, X., Eastham, J., Giltnane, J. M., Zou, W., Zijlstra, A., Tabatsky, E., . . . Koeppen, H. (2024). Automated tumor immunophenotyping predicts clinical benefit from anti‐PD‐L1 immunotherapy. Wiley. https://doi.org/10.1002/path.6274
Chicago Style (17th ed.) CitationLi, Xiao, et al. Automated Tumor Immunophenotyping Predicts Clinical Benefit from Anti‐PD‐L1 Immunotherapy. Wiley, 2024. https://doi.org/10.1002/path.6274.
MLA (9th ed.) CitationLi, Xiao, et al. Automated Tumor Immunophenotyping Predicts Clinical Benefit from Anti‐PD‐L1 Immunotherapy. Wiley, 2024. https://doi.org/10.1002/path.6274.
Warning: These citations may not always be 100% accurate.